In Vitro and in Silico Studies of Potential Coronavirus-Specific 3C-Like Protease Inhibitors.
Chem Pharm Bull (Tokyo)
; 70(3): 195-198, 2022 Mar 01.
Article
in En
| MEDLINE
| ID: mdl-34955489
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Protease Inhibitors
/
COVID-19 Drug Treatment
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Chem Pharm Bull (Tokyo)
Year:
2022
Document type:
Article